Uncertainty, error and informed consent to challenge trials of COVID-19 vaccines: response to Steel et al

Journal of Medical Ethics 46 (12):813-814 (2020)
  Copy   BIBTEX

Abstract

In a recent article, Steel, Buchak and Eyal argue that current levels of uncertainty do not present a good reason to bar controlled human infection trials of COVID-19 vaccines from proceeding. We argue that their argumentation for this conclusion is flawed. SBE are mistaken about the effects which different forms of ignorance have on participants’ ability to provide valid informed consent. Decision-makers considering whether to allow such trials, we argue, must ultimately consider the likelihood that consent to participation in such trials under current conditions would be valid, and whether this likelihood is high enough to permit such trials. This is a question that SBE completely ignore. We conclude that there indeed are valid concerns about conducting CHI trials given the current state of knowledge about COVID-19, concerns which SBE fail to address.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 97,335

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Phase 1 oncology trials and informed consent.Franklin G. Miller & Steven Joffe - 2013 - Journal of Medical Ethics 39 (12):761-764.
Informed consent to HIV cure research.Danielle Bromwich & Joseph R. Millum - 2017 - Journal of Medical Ethics 43 (2):108-113.
Must research participants understand randomization?David Wendler - 2009 - American Journal of Bioethics 9 (2):3 – 8.

Analytics

Added to PP
2020-09-09

Downloads
60 (#284,519)

6 months
16 (#255,707)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Ori Lev
Sapir College
Arnon Keren
University of Haifa

Citations of this work

Add more citations